According to health professionals, Mycoplasma genitalium is developing resistance to antibiotics at an alarming rate. Much like chlamydia, many people...
SpeeDx has significantly contributed to the success and development of the Australian MedTech industry. The CSIRO’s Medical Technologies and Pharmaceutical...
We are happy to announce our Chief Technology Officer, Elisa Mokany, has won the "Outstanding Achievement" award at the Medical...
SpeeDx Multiplexed VZV, Herpes, Syphilis Assay Receives CE-IVD Mark SpeeDx Pty. Ltd. has announced that it has received CE-IVD marking for...
SpeeDx's Alison Todd frontline fighter in the war on superbugs Alison Todd co-founded SpeeDx with Elisa Mokany in 2008. The company...
The macrolide azithromycin is recommended for treatment of Mycoplasma genitalium infection; however, M. genitalium strains possessing macrolide resistance-mediating mutations (MRMMs)...